Johan Swanepoel/Shutterstock
The FDA just approved a new preventative migraine treatment.
The drug, Aimovig, is the first of a new class of medications that's going after the huge migraine market.
An estimated 38 million Americans have migraines and around a third of those people would be eligible for preventive treatment.
The FDA just approved a migraine treatment that's the first of a new class of medications.
The drug is called Aimovig, and it's made by Amgen in partnership with Novartis. It will cost $6,900 a year. See the rest of the story at Business Insider NOW WATCH: Why so many...Read more ...